Skip to main content

Table 1 Clinical and demographic characteristics among the total participants, control participants and MI patients

From: Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction

 

Total (n = 1224)

Controls (n = 729)

MI patients (n = 495)

nonMACCE (n = 1050)

MACCE (n = 174)

P value

nonMACCE (n = 678)

MACCE (n = 51)

P value

nonMACCE (n = 372)

MACCE (n = 123)

P value

Male, n (%)

641 (61.1%)

118 (67.9%)

0.434

334 (49.3%)

18 (35.3%)

0.288

307 (82.5%)

100 (81.3%)

0.938

Age (years)

55.05 ± 10.92

60.86 ± 11.82

< 0.001

54.53 ± 9.96

59.76 ± 9.80

0.006

56.53 ± 12.38

63.01 ± 12.47

< 0.001

BMI (kg/m2)

25.83 ± 3.56

25.54 ± 3.30

0.419

26.25 ± 3.91

25.88 ± 3.51

0.703

25.63 ± 3.26

25.29 ± 3.25

0.488

Hypertension, n (%)

450 (42.9%)

88 (50.6%)

0.246

300 (44.3%)

24 (47.1%)

0.796

105 (28.2%)

64 (52.0%)

0.002

Smoker, n (%)

411 (39.1%)

65 (37.4%)

0.816

195 (28.8%)

10 (19.6%)

0.338

216 (58.1%)

55 (44.7%)

0.180

Drinker, n (%)

324 (30.9%)

47 (27.0%)

0.493

172 (25.4%)

8 (15.7%)

0.241

152 (40.9%)

39 (31.7%)

0.231

Diabetes, n (%)

156 (14.9%)

42 (24.1%)

0.014

72 (10.6%)

8 (15.7%)

0.361

84 (22.6%)

34 (27.6%)

0.411

Glucose (mmol/L)

5.45 (4.71, 7.47)

7.16 (5.27, 9.36)

< 0.001

4.94 (4.53, 5.64)

4.76 (4.29, 5.29)

0.086

7.58 (6.35, 10.30)

8.01 (6.74, 10.58)

0.027

TG (mmol/L)

1.55 (1.05, 2.25)

4.28 (3.56, 5.04)

0.014

1.51 (1.02, 2.13)

1.25 (0.955, 1.705)

0.139

1.60 (1.08, 2.48)

1.42 (0.865, 2.10)

0.189

TC (mmol/L)

4.34 ± 1.07

4.37 ± 1.21

0.909

4.24 ± 0.94

4.07 ± 0.91

0.355

4.66 ± 1.18

4.71 ± 1.37

0.785

HDL-C (mmol/L)

1.08 ± 0.29

1.02 ± 0.27

0.014

1.12 ± 0.32

1.12 ± 0.28

0.992

1.04 ± 0.23

1.00 ± 0.24

0.257

LDL-C (mmol/L)

2.79 ± 0.86

2.86 ± 0.98

0.331

2.69 ± 0.8

2.59 ± 0.74

0.494

3.02 ± 0.89

3.04 ± 1.18

0.895

ApoA (mmol/L)

1.22 ± 0.31

1.16 ± 0.27

0.018

1.23 ± 0.26

1.13 ± 0.24

0.032

1.20 ± 0.44

1.19 ± 0.29

0.795

ApoB (mmol/L)

0.87 ± 0.30

0.88 ± 0.33

0.792

0.85 ± 0.25

0.82 ± 0.26

0.469

0.94 ± 0.40

0.94 ± 0.41

0.987

Lp (a) (mmol/L)

144.80 (88.13, 253.53)

157.99 (99.41, 265.90)

0.622

137.79 (86.61, 232.21)

137.48 (97.28, 224.08)

0.961

165.00 (91.51, 278.47)

176.68 (105.91, 301.97)

0.763

SBP (mmHg)

123.43 ± 17.08

122.84 ± 20.03

0.715

125.39 ± 16.39

124.12 ± 19.62

0.666

118.93 ± 16.77

121.54 ± 20.66

0.260

DBP (mmHg)

122.84 ± 20.03

76.29 ± 11.78

0.292

76.71 ± 11.02

75.74 ± 13.70

0.663

75.26 ± 12.55

73.85 ± 13.24

0.398

  1. The continuous variables are defined as the mean ± SD or median (quartile). Categorical variables are expressed as percentages
  2. The P value of the continuous variables was calculated by the independent samples t-test. The P value of the categorical variables was calculated by the Chi-square test
  3. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, ApoA apolipoprotein A, ApoB apolipoprotein B, Lp(a) lipoprotein(a)